These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 9610608)
1. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency. Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221 [TBL] [Abstract][Full Text] [Related]
4. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632 [TBL] [Abstract][Full Text] [Related]
5. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. Hara I; Miyake H; Hara S; Arakawa S; Kamidono S J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973 [TBL] [Abstract][Full Text] [Related]
6. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis. Gomez DE; De Lorenzo MS; Alonso DF; Andrade ZA Am J Trop Med Hyg; 1999 Jul; 61(1):9-13. PubMed ID: 10432047 [TBL] [Abstract][Full Text] [Related]
7. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566 [TBL] [Abstract][Full Text] [Related]
8. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Birkedal-Hansen B; Pavelic ZP; Gluckman JL; Stambrook P; Li YQ; Stetler-Stevenson WG Oral Dis; 2000 Nov; 6(6):376-82. PubMed ID: 11355270 [TBL] [Abstract][Full Text] [Related]
9. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952 [TBL] [Abstract][Full Text] [Related]
10. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix. Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129 [TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
12. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma. Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622 [TBL] [Abstract][Full Text] [Related]
13. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106 [TBL] [Abstract][Full Text] [Related]
14. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409 [TBL] [Abstract][Full Text] [Related]
15. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503 [TBL] [Abstract][Full Text] [Related]
16. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137 [TBL] [Abstract][Full Text] [Related]
17. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Flannelly J; Chambers MG; Dudhia J; Hembry RM; Murphy G; Mason RM; Bayliss MT Osteoarthritis Cartilage; 2002 Sep; 10(9):722-33. PubMed ID: 12202125 [TBL] [Abstract][Full Text] [Related]